By Brazil Stock Guide – Brazil’s supplementary health sector closed the first quarter of 2026 still in the black, but with clearer signs of operating pressure. The sector regulated by ANS posted R$101 billion in total revenue, up 8.7% from the same period a year earlier, while expenses rose 11% to R$93.1 billion. Consolidated net income fell 11.6% to R$6.3 billion.
The overall picture remained positive. According to ANS, 77.7% of operators ended the quarter with positive net income, and medical-hospital operators — the sector’s core segment — generated R$6 billion in net profit. Aggregate operating income came to R$3.4 billion, while financial income reached R$3.6 billion, underscoring the growing importance of financial investments to sector profitability.
The figures also highlight the scale of Brazil’s supplementary health market. The medical-hospital segment included 693 operators and nearly 53 million beneficiaries at the end of March. The portfolio remains heavily concentrated in group plans: 84% of beneficiaries were in corporate or affinity-based contracts, versus 16% in individual or family plans. In practice, that means the sector remains closely tied to employment conditions, household income and companies’ ability to absorb price increases.
ANS Caveats
The numbers, however, require some caution. In presenting the results, Washington Oliveira Alves of ANS stressed that the figures released were raw financial data, submitted by the operators themselves, without prior agency-level adjustment or individualized treatment. He also noted that the decline in profit was significantly influenced by one large operator that adopted a new provisioning policy for its portfolio.
According to Alves, this was a non-recurring effect and accounted for an important share of the decline in aggregate sector profit. That caveat matters because it prevents an overly negative reading of the sector as a whole. Without that extraordinary provisioning effect, the operating result of medical-hospital operators could have come closer to — or even exceeded — the sector’s financial result.
Even so, the data expose a more structural vulnerability. Financial income already accounts for nearly half of the sector’s final earnings. Medical-hospital operators ended March with roughly R$140.5 billion in financial investments, including both unrestricted assets and regulatory backing assets. In a high-interest-rate environment, that cash buffer helps cushion margins squeezed by medical costs, claims ratios and care-related expenses.
Large Operators
On an individual basis, Bradesco Saúde stood out as the clearest positive among the large operators. The company posted R$1.02 billion in operating income, R$818.5 million in financial income and R$1.11 billion in net income in the first quarter, with 3.32 million medical-hospital beneficiaries. Amil Assistência Médica Internacional also remained profitable, reporting R$519.7 million in net income, R$473.4 million in operating income and R$220.4 million in financial income, with 3.12 million medical-hospital beneficiaries and 2.68 million dental beneficiaries.
Among companies tied to the Hapvida group, the panel showed positive results for the two main listed operations. Hapvida Assistência Médica posted R$275.3 million in net income, with R$302.9 million in operating income, R$26.9 million in financial income and 4.38 million medical-hospital beneficiaries. Notre Dame Intermédica Saúde also ended the quarter in the black, with R$202.2 million in net income, despite negative financial income of R$97.5 million. That operation had 3.29 million medical-hospital beneficiaries and 2.60 million dental beneficiaries.
Porto Seguro Saúde also ranked among the positive highlights, with R$234.6 million in net income. Within the Unimed system, the picture was more mixed: Unimed Seguros Saúde posted R$238.2 million in profit, and Unimed do Brasil — Confederação Nacional das Cooperativas Médicas earned R$165.9 million. Some regional cooperatives, however, reported losses, including Unimed do Estado do Rio de Janeiro, with a R$47.5 million loss, Unimed Teresina, with a R$22.5 million loss, and Unimed Vale do Aço, with a R$15.9 million loss.
SulAmérica in the Red
SulAmérica Companhia de Seguro Saúde was on the opposite end of the spectrum. The operator posted negative operating income of R$2.06 billion, R$2.7 billion in provisions and a net loss of R$694.7 million, the largest individual negative result in the quarter’s ANS panel. Even with positive financial income of R$407.8 million and positive equity income of R$270.4 million, the company was unable to offset the impact of the provisioning.
SulAmérica’s case requires an additional caveat. The ANS panel figure diverges from the parent company’s corporate financial statements. In Rede D’Or’s financial disclosures, the line item Cia Saúde – SulAmérica shows positive operating income of R$1.13 billion and positive profit for the period of R$736.6 million in the first quarter. That difference does not, by itself, mean one of the figures is wrong: the ANS panel follows a regulatory logic, based on the operator’s registration and data submitted through DIOPS, while Rede D’Or’s quarterly filing follows corporate accounting and consolidation standards.
Still, the divergence reinforces the need for a clearer explanation of how the two figures reconcile. For readers, the key point is that the regulatory panel captured a multi-billion-real provisioning event that made SulAmérica the most sensitive case of the quarter, while the parent company presented a positive corporate view of the same line of business. Contacted by Brazil Stock Guide, SulAmérica did not respond by the time this story was published. The company’s response can still be added in an updated version.